Despite the fact that hackathons and digital innovation contests have emerged as substantial intermediaries in open innovation and entrepreneurship, knowledge about how hackathons and digital innovation contests impact innovation in cities is restricted. There is also a scarcity of models that aid in the organization and evaluation of digital innovation contests. The purpose of this article is to examine the stages for organizing hackathons and digital innovation contests and identifies factors leading to the successful implementation of open data hackathons and digital innovation competitions. Three hackathons and innovation contests held in Thessaloniki between 2014 and 2018 were studied. The proposed framework provides practitioners with options to hold digital contests while also advancing the state of the art in the fields of open data and innovation competitions. Organizers of hackathon events may find this paper useful because they can learn about the factors that must be taken into account to ensure the success of these events.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10070910 | PMC |
| http://dx.doi.org/10.1016/j.heliyon.2023.e14868 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Data and AI-driven synthetic binding protein discovery.
Trends Pharmacol Sci
January 2025
School of Pharmaceutical Sciences, Chongqing University, Chongqing 401331, China; Western (Chongqing) Collaborative Innovation Center for Intelligent Diagnostics and Digital Medicine, Chongqing National Biomedicine Industry Park, Chongqing 401329, China. Electronic address:
Synthetic binding proteins (SBPs) are a class of protein binders that are artificially created and do not exist naturally. Their broad applications in tackling challenges of research, diagnostics, and therapeutics have garnered significant interest. Traditional protein engineering is pivotal to the discovery of SBPs.
View Article and Find Full Text PDFDigital health technologies enabling the transition from pregnancy to early parenthood: A scoping review.
Z Evid Fortbild Qual Gesundhwes
January 2025
Department Digital Health Sciences and Biomedicine, School of Life Sciences, University of Siegen, Siegen, Germany.
Background: Pregnant women and their families, especially those navigating chronic illness or challenging life situations, often seek information and counseling. The pregnancy period and the transition to parenthood can exacerbate these circumstances, leaving families particularly vulnerable. Addressing stressful situations becomes a hurdle in this context.
View Article and Find Full Text PDFFacilitators and Barriers of Large Language Model Adoption Among Nursing Students: A Qualitative Descriptive Study.
J Adv Nurs
January 2025
Department of Urology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Aim: To explore nursing students' perceptions and experiences of using large language models and identify the facilitators and barriers by applying the Theory of Planned Behaviour.
Design: A qualitative descriptive design.
Method: Between January and June 2024, we conducted individual semi-structured online interviews with 24 nursing students from 13 medical universities across China.
MiRNAs and extracellular vesicles in psychiatry: Potential biomarkers, therapeutic advances, and animal models.
Eur Neuropsychopharmacol
January 2025
Institute of Biomedical Research of Barcelona (IIBB), Spanish National Research Council (CSIC), 08036 Barcelona, Spain; Systems Neuropharmacology Group, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), 08036 Barcelona, Catalonia, Spain; Biomedical Research Networking Centre Consortium on Mental Health (CIBERSAM), Instituto de Salud Carlos III, 28029 Madrid, Spain. Electronic address:
Detection rate for ESR1 mutations is higher in circulating-tumor-cell-derived genomic DNA than in paired plasma cell-free DNA samples as revealed by ddPCR.
Mol Oncol
January 2025
Analysis of Circulating Tumor Cells Lab, Laboratory of Analytical Chemistry, Department of Chemistry, University of Athens, Greece.
Plasma cell-free DNA (cfDNA) analysis to track estrogen receptor 1 (ESR1) mutations is highly beneficial for the identification of tumor molecular dynamics and the improvement of personalized treatments for patients with metastatic breast cancer (MBC). Plasma-cfDNA is, up to now, the most frequent liquid biopsy analyte used to evaluate ESR1 mutational status. Circulating tumor cell (CTC) enumeration and molecular characterization analysis provides important clinical information in patients with MBC.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!